Search clinical trials for: Patritumab Deruxtecan
Total 140 results
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingMelanoma | Cervical Cancer | Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Prostate Cancer | Bladder Cancer | Advanced Solid Tumor | Endometrial Cancer | Ovarian Carcinoma | Pancreatic CarcinomaUnited States, Taiwan, Japan
-
The Netherlands Cancer InstituteDaiichi Sankyo, Inc.Not yet recruitingEGFR Gene Mutation | Non-Small Cell Lung Carcinoma | Advanced Non-Small Cell Squamous Lung Cancer
-
SCRI Development Innovations, LLCDaiichi Sankyo, Inc.RecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerUnited States
-
Daiichi Sankyo, Inc.TerminatedMetastatic Colorectal CancerUnited States, Spain, Belgium, Japan, France, United Kingdom, Italy, Poland
-
Samsung Medical CenterNot yet recruitingSolid Tumor, AdultKorea, Republic of
-
Daiichi Sankyo Co., Ltd.Daiichi Sankyo, Inc.CompletedMetastatic Breast CancerUnited States, Japan
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Daiichi SankyoActive, not recruitingEGFR L858R | EGFR Exon 19 Deletion | Nonsquamous Non-small Cell Lung CancerKorea, Republic of, United States, Netherlands, Spain, United Kingdom, Japan, Austria, Belgium, Italy, France, Taiwan, Germany, Australia, Singapore, China, Hong Kong, Norway, Canada, Poland, Portugal, Switzerland
-
SOLTI Breast Cancer Research GroupDaiichi Sankyo, Inc.Active, not recruiting
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.RecruitingMetastatic Breast CancerFrance
-
Mustafa Khasraw, MBChB, MD, FRCP, FRACPDaiichi SankyoNot yet recruitingA Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases (PARAMETer)Brain Metastases, AdultUnited States
-
MedSIRDaiichi SankyoRecruitingMetastatic Breast Cancer | Solid Tumor, Adult | Advanced Non-Small Cell Squamous Lung CancerSpain, Austria
-
Daiichi SankyoAvailableEpidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung CancerUnited States
-
Sorlandet Hospital HFRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
Daiichi Sankyo, Inc.AstraZenecaRecruiting
-
Daiichi SankyoRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Spain, Japan, Netherlands, Taiwan
-
Daiichi Sankyo, Inc.CompletedSolid TumorsUnited States
-
SOLTI Breast Cancer Research GroupDaiichi Sankyo, Inc.Active, not recruiting
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, Japan, France, Hungary, Netherlands
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Taiwan, Japan
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
Daiichi SankyoAstraZenecaAvailableAdvanced Non-Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingRecurrent or Metastatic Solid TumorsUnited States
-
Medical University of ViennaDaiichi Sankyo, Inc.Recruiting
-
AstraZenecaRecruitingAdvanced Solid MalignanciesUnited States, Korea, Republic of, Spain, Australia, Sweden, Germany, United Kingdom
-
AstraZenecaDaiichi SankyoActive, not recruitingCarcinoma, Non-Small-Cell Lung | Triple Negative Breast CancerChina
-
Fudan UniversityNot yet recruitingTriple-Negative Breast CancerChina
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
Fudan UniversityActive, not recruiting
-
Sarah Sammons, MDDaiichi SankyoRecruitingBreast Cancer | Breast Cancer Female | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | ER-negative Breast Cancer | ER Positive Breast CancerUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingAdvanced Solid Tumor | Malignant Solid TumorUnited States, Japan
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruiting
-
Daiichi SankyoMerck Sharp & Dohme LLCRecruitingExtensive-stage Small-cell Lung CancerUnited States, Korea, Republic of, Spain, Taiwan, France, Japan, Germany, China, Austria
-
AstraZenecaDaiichi Sankyo Co., Ltd.CompletedGastric or Gastroesophageal Junction (GEJ) AdenocarcinomaChina
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerAustralia, China, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
National Cancer Institute (NCI)SuspendedOsteosarcoma | Recurrent OsteosarcomaUnited States
-
Yonsei UniversityNot yet recruiting
-
MedSIRDaiichi SankyoNot yet recruitingBreast Cancer | Metastatic Breast Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Daiichi Sankyo, Inc.CompletedNSCLC (Advanced Non-small Cell Lung Cancer)Ukraine, United Kingdom, United States, Bulgaria, Belgium, Germany, Hungary, Austria, Italy, Israel, Lithuania, Romania, Slovenia
-
Daiichi Sankyo, Inc.TerminatedHead and Neck NeoplasmsFrance, Hungary, United Kingdom, Belgium, Germany, Romania, Poland
-
Daiichi Sankyo, Inc.CompletedSquamous Cell Carcinoma of the Head and NeckUnited Kingdom
-
Daiichi Sankyo Co., Ltd.AstraZeneca; Daiichi Sankyo, Inc.RecruitingTriple Negative Breast Cancer | Non-small Cell Lung Cancer | Hormone Receptor Positive Breast CancerUnited States, Japan
-
National Cancer Center Hospital EastDaiichi Sankyo Co., Ltd.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
Medical University of ViennaDaiichi Sankyo, Inc.CompletedBreast Cancer Stage IVAustria
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Daiichi Sankyo, Inc.ParexelTerminatedLung Cancer | Non-small Cell Lung CancerUnited States, Italy, Poland, United Kingdom, Belgium, Spain, Canada, Germany, Czechia, Hungary